M.D.C. (MDC) Stock Forecast, Price Target & Predictions


OverviewRevenueFinancialsChart

MDC Stock Forecast


M.D.C. stock forecast is as follows: an average price target of $36.83 (represents a -41.52% downside from MDC’s last price of $62.98) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.

MDC Price Target


The average price target for M.D.C. (MDC) is $36.83 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $44.00 to $27.00. This represents a potential -41.52% downside from MDC's last price of $62.98.

MDC Analyst Ratings


Hold

According to 6 Wall Street analysts, M.D.C.'s rating consensus is 'Hold'. The analyst rating breakdown for MDC stock is 0 'Strong Buy' (0.00%), 2 'Buy' (33.33%), 4 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

M.D.C. Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 03, 2023Michael RehautJ.P. Morgan$39.50$42.80-7.71%-37.28%
Nov 22, 2022J.P. Morgan$28.00$31.11-10.00%-55.54%
Aug 01, 2022Raymond James$44.00$36.2521.38%-30.14%
Jul 12, 2022J.P. Morgan$38.00$35.636.65%-39.66%
Jun 17, 2022Deepa RaghavanWells Fargo$27.00$29.64-8.91%-57.13%

The latest M.D.C. stock forecast, released on Nov 03, 2023 by Michael Rehaut from J.P. Morgan, set a price target of $39.50, which represents a -7.71% decrease from the stock price at the time of the forecast ($42.80), and a -37.28% decrease from MDC last price ($62.98).

M.D.C. Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$39.50
Last Closing Price$62.98$62.98$62.98
Upside/Downside-100.00%-100.00%-37.28%

In the current month, the average price target of M.D.C. stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to M.D.C.'s last price of $62.98. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Nov 03, 2023CitigroupHoldHoldHold
Nov 02, 2023Seaport GlobalBuyUpgrade
Jul 14, 2023Raymond JamesStrong BuyOutperformUpgrade
Oct 21, 2022Goldman SachsNeutralInitialise
Oct 21, 2022BarclaysEqual-WeightInitialise
Aug 01, 2022Raymond JamesStrong BuyStrong BuyHold
Jun 17, 2022Wells FargoUnderweightEqual-WeightDowngrade
Jun 17, 2022Wells FargoUnderweightDowngrade

M.D.C.'s last stock rating was published by Citigroup on Nov 03, 2023. The company gave MDC a "Hold" rating, the same as its previous rate.

M.D.C. Financial Forecast


M.D.C. Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
Revenue--------$36.70M-$32.62M$1.05B$1.52B$1.44B$1.49B$1.27B$1.47B$1.30B$1.40B$1.09B$1.23B$1.04B$919.72M$718.97M$1.10B$772.66M$751.44M$664.68M$881.88M$785.64M
Avg Forecast$1.57B$1.39B$1.33B$1.01B$1.41B$1.18B$1.25B$1.13B$1.29B$1.13B$939.10M$880.35M$1.32B$1.39B$1.43B$1.22B$1.54B$1.35B$1.34B$1.13B$1.20B$953.94M$808.41M$729.67M$1.09B$772.33M$738.72M$603.90M$1.08B$803.87M
High Forecast$1.72B$1.53B$1.46B$1.10B$1.55B$1.30B$1.38B$1.23B$1.31B$1.20B$1.03B$963.78M$1.44B$1.52B$1.57B$1.33B$1.69B$1.48B$1.46B$1.24B$1.32B$1.04B$885.02M$798.82M$1.19B$845.52M$808.72M$661.13M$1.30B$964.64M
Low Forecast$1.44B$1.28B$1.22B$922.28M$1.29B$1.08B$1.16B$1.03B$1.28B$1.08B$860.52M$806.69M$1.21B$1.27B$1.31B$1.12B$1.41B$1.24B$1.23B$1.04B$1.10B$874.12M$740.76M$668.62M$994.61M$707.71M$676.91M$553.37M$865.84M$643.10M
# Analysts----11224422111122210148810137791620
Surprise %--------0.03%-0.03%1.19%1.15%1.04%1.04%1.04%0.95%0.96%1.05%0.96%1.02%1.09%1.14%0.99%1.02%1.00%1.02%1.10%0.81%0.98%

M.D.C.'s average Quarter revenue forecast for Mar 24 based on 2 analysts is $1.13B, with a low forecast of $1.03B, and a high forecast of $1.23B. MDC's average Quarter revenue forecast represents a 2970.36% increase compared to the company's last Quarter revenue of $36.70M (Dec 23).

M.D.C. EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
# Analysts----11224422111122210148810137791620
EBITDA--------$118.57M-$74.25M$114.47M$120.31M$192.55M$266.21M$208.53M$216.88M$200.44M$214.72M$151.31M$179.58M$133.37M$118.01M$53.71M$119.82M$68.34M$79.39M$60.48M$75.21M$72.87M
Avg Forecast$476.43M$422.27M$403.18M$305.00M$427.91M$358.55M$378.85M$238.66M$291.94M$243.75M$283.16M$216.96M$265.40M$221.59M$257.42M$197.24M$241.27M$201.45M$200.62M$142.85M$131.32M$103.86M$54.74M$63.83M$105.67M$74.63M$72.36M$57.51M$89.13M$74.53M
High Forecast$521.58M$462.29M$441.39M$333.91M$468.46M$392.53M$418.89M$286.39M$350.33M$292.50M$339.80M$260.35M$318.48M$265.91M$308.91M$236.68M$289.53M$241.74M$240.74M$171.42M$157.58M$124.63M$65.69M$76.60M$126.80M$89.55M$86.83M$69.01M$106.96M$89.44M
Low Forecast$436.56M$386.94M$369.45M$279.48M$392.11M$328.55M$351.13M$190.92M$233.55M$195.00M$226.53M$173.57M$212.32M$177.27M$205.94M$157.79M$193.02M$161.16M$160.50M$114.28M$105.05M$83.08M$43.79M$51.07M$84.54M$59.70M$57.89M$46.01M$71.31M$59.62M
Surprise %--------0.41%-0.26%0.53%0.45%0.87%1.03%1.06%0.90%1.00%1.07%1.06%1.37%1.28%2.16%0.84%1.13%0.92%1.10%1.05%0.84%0.98%

2 analysts predict MDC's average Quarter EBITDA for Mar 24 to be $238.66M, with a high of $286.39M and a low of $190.92M. This is 101.27% upper than M.D.C.'s previous annual EBITDA (Dec 23) of $118.57M.

M.D.C. Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
# Analysts----11224422111122210148810137791620
Net Income--------$119.51M-$93.49M$80.70M$79.78M$144.40M$189.54M$148.42M$162.66M$145.95M$154.35M$110.69M$147.49M$98.94M$84.40M$36.76M$92.59M$50.58M$54.59M$40.55M$54.73M$53.39M
Avg Forecast$134.74M$108.86M$105.82M$78.41M$119.26M$102.77M$104.29M$169.25M$218.95M$177.49M$200.99M$153.86M$199.05M$161.35M$182.72M$139.87M$180.95M$146.68M$144.22M$104.50M$107.85M$77.04M$39.15M$43.69M$81.65M$55.23M$49.76M$38.56M$64.86M$54.61M
High Forecast$151.34M$122.27M$118.85M$88.07M$133.96M$115.43M$122.19M$203.10M$262.74M$212.98M$241.19M$184.63M$238.86M$193.62M$219.26M$167.85M$217.14M$176.02M$173.06M$125.40M$129.42M$92.45M$46.98M$52.42M$97.98M$66.28M$59.71M$46.27M$77.83M$65.53M
Low Forecast$120.09M$97.02M$94.31M$69.88M$106.29M$91.59M$90.28M$135.40M$175.16M$141.99M$160.79M$123.09M$159.24M$129.08M$146.17M$111.90M$144.76M$117.35M$115.37M$83.60M$86.28M$61.63M$31.32M$34.95M$65.32M$44.18M$39.80M$30.84M$51.89M$43.68M
Surprise %--------0.55%-0.47%0.52%0.40%0.89%1.04%1.06%0.90%1.00%1.07%1.06%1.37%1.28%2.16%0.84%1.13%0.92%1.10%1.05%0.84%0.98%

M.D.C.'s average Quarter net income forecast for Mar 24 is $169.25M, with a range of $135.40M to $203.10M. MDC's average Quarter net income forecast represents a 41.62% increase compared to the company's last Quarter net income of $119.51M (Dec 23).

M.D.C. SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
# Analysts----11224422111122210148810137791620
SG&A--------$126.86M-$106.73M$94.99M$131.80M$141.44M$133.85M$129.31M$130.02M$120.12M$128.86M$114.99M$117.95M$103.63M$92.32M$89.32M$105.10M$92.72M$82.71M$82.26M$93.37M$83.52M
Avg Forecast$1.23B$1.09B$1.04B$786.82M$1.10B$924.95M$977.32M$147.46M$175.02M$146.07M$141.93M$134.05M$159.11M$132.79M$129.03M$121.87M$144.64M$120.72M$120.40M$108.56M$86.25M$80.70M$42.82M$106.15M$92.69M$101.24M$75.38M$78.22M$110.66M$85.42M
High Forecast$1.35B$1.19B$1.14B$861.38M$1.21B$1.01B$1.08B$176.95M$210.02M$175.28M$170.32M$160.86M$190.93M$159.35M$154.84M$146.24M$173.57M$144.86M$144.48M$130.27M$103.50M$96.84M$51.39M$127.38M$111.22M$121.49M$90.46M$93.86M$132.79M$102.51M
Low Forecast$1.13B$998.20M$953.07M$720.98M$1.01B$847.55M$905.81M$117.97M$140.02M$116.85M$113.55M$107.24M$127.29M$106.23M$103.22M$97.49M$115.72M$96.57M$96.32M$86.85M$69.00M$64.56M$34.26M$84.92M$74.15M$80.99M$60.31M$62.57M$88.52M$68.34M
Surprise %--------0.72%-0.75%0.71%0.83%1.07%1.04%1.06%0.90%1.00%1.07%1.06%1.37%1.28%2.16%0.84%1.13%0.92%1.10%1.05%0.84%0.98%

M.D.C.'s average Quarter SG&A projection for Mar 24 is $147.46M, based on 2 Wall Street analysts, with a range of $117.97M to $176.95M. The forecast indicates a 16.24% rise compared to MDC last annual SG&A of $126.86M (Dec 23).

M.D.C. EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
# Analysts----11224422111122210148810137791620
EPS----------$1.28$1.10$1.11$2.03$2.66$2.09$2.31$2.07$2.19$1.58$2.27$1.43$1.23$0.54$1.37$0.75$0.81$0.61$0.83$0.81
Avg Forecast$1.77$1.43$1.39$1.03$1.57$1.35$1.37$1.03$1.50$1.20$0.74$0.54$1.52$2.24$2.50$1.91$2.49$2.01$1.99$1.44$1.60$1.13$0.77$0.64$1.17$0.81$0.73$0.56$1.28$0.90
High Forecast$1.99$1.61$1.56$1.16$1.76$1.52$1.61$1.23$1.61$1.26$0.83$0.60$1.71$2.52$2.81$2.14$2.80$2.25$2.23$1.62$1.80$1.27$0.87$0.72$1.32$0.90$0.82$0.63$1.54$1.08
Low Forecast$1.58$1.27$1.24$0.92$1.40$1.20$1.19$0.89$1.44$1.11$0.66$0.48$1.36$2.00$2.23$1.70$2.22$1.79$1.77$1.28$1.43$1.01$0.69$0.57$1.04$0.72$0.65$0.50$1.02$0.72
Surprise %--------0.00%-1.74%2.04%0.73%0.90%1.06%1.10%0.93%1.03%1.10%1.10%1.42%1.26%1.59%0.84%1.17%0.93%1.12%1.09%0.65%0.90%

According to 2 Wall Street analysts, M.D.C.'s projected average Quarter EPS for Mar 24 is $1.03, with a low estimate of $0.89 and a high estimate of $1.23. This represents a 64066.87% increase compared to MDC previous annual EPS of - (Dec 23).

M.D.C. Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
BZHBeazer Homes USA$30.01$45.0049.95%Buy
TPHTri Pointe Homes$38.18$51.0033.58%Hold
MHOM/I Homes$150.73$197.5031.03%Strong Buy
LGIHLGI Homes$96.47$125.0029.57%Hold
MTHMeritage Homes$163.80$206.8026.25%Buy
TMHCTaylor Morrison Home$63.84$77.2020.93%Buy
KBHKB Home$70.44$77.409.88%Buy
CCSCentury Communities$81.31$60.67-25.38%Buy

MDC Forecast FAQ


Is M.D.C. a good buy?

No, according to 6 Wall Street analysts, M.D.C. (MDC) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 33.33% of MDC's total ratings.

What is MDC's price target?

M.D.C. (MDC) average price target is $36.83 with a range of $27 to $44, implying a -41.52% from its last price of $62.98. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will M.D.C. stock go up soon?

According to Wall Street analysts' prediction for MDC stock, the company can go down by -41.52% (from the last price of $62.98 to the average price target of $36.83), down by -30.14% based on the highest stock price target, and down by -57.13% based on the lowest stock price target.

Can M.D.C. stock reach $90?

MDC's average twelve months analyst stock price target of $36.83 does not support the claim that M.D.C. can reach $90 in the near future.

What are M.D.C.'s analysts' financial forecasts?

M.D.C.'s analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $4.97B (high $5.45B, low $4.56B), average EBITDA is $1.4B (high $1.57B, low $1.26B), average net income is $495.57M (high $574.68M, low $423.56M), average SG&A $3.15B (high $3.48B, low $2.88B), and average EPS is $5.31 (high $6.11, low $4.67). MDC's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $5.3B (high $5.81B, low $4.86B), average EBITDA is $1.61B (high $1.76B, low $1.47B), average net income is $427.83M (high $480.54M, low $381.29M), average SG&A $4.15B (high $4.54B, low $3.8B), and average EPS is $5.62 (high $6.31, low $5.01).

Did the MDC's actual financial results beat the analysts' financial forecasts?

Based on M.D.C.'s last annual report (Dec 2023), the company's revenue was $122.57M, which missed the average analysts forecast of $4.24B by -97.11%. Apple's EBITDA was $376.22M, missing the average prediction of $1.04B by -63.68%. The company's net income was $401M, missing the average estimation of $751.29M by -46.62%. Apple's SG&A was $429.89M, missing the average forecast of $597.07M by -28.00%. Lastly, the company's EPS was $0.0055, missing the average prediction of $3.97 by -99.86%. In terms of the last quarterly report (Dec 2023), M.D.C.'s revenue was $36.7M, missing the average analysts' forecast of $1.29B by -97.15%. The company's EBITDA was $118.57M, missing the average prediction of $291.94M by -59.38%. M.D.C.'s net income was $119.51M, missing the average estimation of $218.95M by -45.42%. The company's SG&A was $126.86M, missing the average forecast of $175.02M by -27.52%. Lastly, the company's EPS was $0.0016, missing the average prediction of $1.5 by -99.89%